The herb medicine formula "Yang Wei Kang Liu" improves the survival of late stage gastric cancer patients and induces the apoptosis of human gastric cancer cell line through Fas/Fas ligand and Bax/Bcl-2 pathways

International Immunopharmacology

Volumn 8, Issue 9, 2008, Pages 1196-1206

  Li, Jie ^a   Sun, Gui Zhi ^a   Lin, Hong Sheng ^a   Pei, Ying Xia ^a   Qi, Xin ^a   An, Cheng ^a   Yu, Jun ^a   Hua, Bao Jin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Apoptosis; Bax Bcl 2; Fas Fas ligand; Gastric carcinoma; Herb medicine; Serum pharmacology

Indexed keywords

CISPLATIN; FAS ANTIGEN; FAS LIGAND; FLUOROURACIL; HERBACEOUS AGENT; MESSENGER RNA; MITOMYCIN C; PROTEIN BAX; PROTEIN BCL 2; YANG WEI KANG LIU;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER SURVIVAL; CHEMOTHERAPY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG SYNTHESIS; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RABBIT; SERUM; SERUM PHARMACOLOGY; STOMACH CANCER;

ACRIDINE ORANGE; ANIMALS; ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUGS, CHINESE HERBAL; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; KARNOFSKY PERFORMANCE STATUS; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SURVIVAL; TETRAZOLIUM SALTS; THIAZOLES;

EID: 46349084239     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.04.007     Document Type: Article

References (41)

1. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 12 (2006) 17-20
2. Xu Y.Q., Xue H.N., Zhu X.Q., and Chen X.D. Clinical observation on treatment for postoperative metastasis of gastric cancer by Jianpi Huoxue Jiedu prescription. Zhong Xi Yi Jie He Xue Bao 1 (2003) 192-194
3. Lu W.P., Sun G.Z., and Piao B.K. Clinical and experimental research in gastric cancer treatment by "Yangwei kang liu" granules. J Trad Chin Med 37 (1996) 350-352
4. Letai A.G. Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8 (2008) 121-132
5. Fulda S., and Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 (2006) 4798-4811
6. Curtin J.F., and Cotter T.G. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15 (2003) 983-992
7. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
8. Li J., Sun G.Z., and Qi X. Effect of "YangWeiKangLiu" granules on peripheral blood T-lymphocyte rDNA transcription activity and Fas expression in gastric cancer metastasis. Chin J Surg Integr 8 (2002) 253-255
9. Tashino S. "Serum pharmacology" and "serum pharmaceutical chemistry": from pharmacology of Chinese traditional medicines to start a new measurement of drug concentration in blood. Ther Drug Monit Res 5 (1988) 54-64
10. Bochu W., Liancai Z., and Qi C. Primary study on the application of Serum Pharmacology in Chinese traditional medicine. Colloids Surf B Biointerfaces 43 (2005) 194-197
11. Block K.I., and Mead M.N. Immune system effects of echinacea, ginseng, and Astragalus: a review. Integr Cancer Ther 2 (2003) 247-267
12. Li W.L., Zheng H.C., Bukuru J., and De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92 (2004) 1-21
13. Ng T.B. Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol 58 (2006) 1007-1019
14. Ye M., Xie W.D., Lei F., Meng Z., Zhao Y.N., Su H., et al. Brazilein, an important immunosuppressive component from Caesalpinia sappan L. Int Immunopharmacol 6 (2006) 426-432
15. Kim D.H., Lee H.J., Oh Y.J., Kim M.J., Kim S.H., Jeong T.S., et al. Iridoid glycosides isolated from Oldenlandia diffusa inhibit LDL-oxidation. Arch Pharm Res 28 (2005) 1156-1160
16. Li Y.K. Medicine serum pharmacology test methods a number of issues. Traditional Chinese Medicine Research & Clinical Pharmacology vol. 10 (1999) 95-97
17. Sirri V., Roussel P., and Hernandez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 31 (2000) 121-126
18. K. Vacharadze, G. Burkadze, G. Turashvili, N. Kiria (2005) Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions. Georgian Med News, 91--3.
19. Qiao L., Pizzolo G., and Melamed M.R. Effects of selected chemotherapeutic agents on PCNA expression in prostate carcinoma cell lines. Urol Res 22 (1994) 171-176
20. Nguyen H.N., Sevin B.U., Averette H.E., Perras J., Ramos R., Donato D., et al. Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines. Cancer Investig. 11 (1993) 264-275
21. Hoye A.T., Davoren J.E., Wipf P., Fink M.P., and Kagan V.E. Targeting mitochondria. Acc Chem Res 41 (2008) 87-97
22. Lalier L., Cartron P.F., Juin P., Nedelkina S., Manon S., Bechinger B., et al. Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12 (2007) 887-896
23. Konopleva M., Zhao S., Xie Z., Segall H., Younes A., Claxton D.F., et al. Apoptosis. Molecules and mechanisms. Adv Exp Med Biol 457 (1999) 217-236
24. Wohlfart S., Sebinger D., Gruber P., Buch J., Polgar D., Krupitza G., et al. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol 164 (2004) 1081-1089
25. Radfar S., Davrinche C., and Hollande E. Serial in vivo loss and in vitro gain of Fas expression and function in human cancerous pancreatic duct cells. Int J Cancer 115 (2005) 214-223
26. von Reyher U., Strater J., Kittstein W., Gschwendt M., Krammer P.H., and Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 58 (1998) 526-534
27. Sikora J., Dworacki G., and Zeromski J. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions. Nat Immun 16 (1998) 244-255
28. Glimelius B., Ekstrom K., Hoffman K., Graf W., Sjoden P.O., Haglund U., et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8 (1997) 163-168
29. Kodera Y., Yamamura Y., Torii A., Uesaka K., Hirai T., Yasui K., et al. Postoperative staging of gastric carcinoma. A comparison between the UICC stage classification and the 12th edition of the Japanese General Rules for Gastric Cancer Study. Scand J Gastroenterol 31 (1996) 476-480
30. Hundahl S.A., Menck H.R., Mansour E.G., and Winchester D.P. The National Cancer Data Base report on gastric carcinoma. Cancer 80 (1997) 2333-2341
31. Kim S.G., Park E.C., Park J.H., Hahm M.I., Lim J.H., and Choi K.S. Initiation and discontinuation of complementary therapy among cancer patients. J Clin Oncol 25 (2007) 5267-5274
32. Ohno S., Tachibana M., Shibakita M., Dhar D.K., Yoshimura H., Kinugasa S., et al. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer. Ann Surg Oncol 7 (2000) 750-757
33. Hofseth L.J., and Wargovich M.J. Inflammation, cancer, and targets of ginseng. J Nutr 137 (2007) 183S-185S
34. Sun J., Liu B.R., Hu W.J., Yu L.X., and Qian X.P. In vitro anticancer activity of aqueous extracts and ethanol extracts of fifteen traditional Chinese medicines on human digestive tumor cell lines. Phytother Res 21 (2007) 1102-1104
35. Zhao Y., Kang L.P., Liu Y.X., Zhao Y., Xiong C.Q., Ma B.P., et al. Three new steroidal saponins from the rhizome of Paris polyphylla. Magn Reson Chem 45 (2007) 739-744
36. Liang Z., He M., Fong W., Jiang Z., and Zhao Z. A comparable, chemical and pharmacological analysis of the traditional Chinese medicinal herbs Oldenlandia diffusa and O. corymbosa and a new valuation of their biological potential. Phytomedicine 15 (2008) 259-267
37. Tin M.M., Cho C.H., Chan K., James A.E., and Ko J.K. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis 28 (2007) 1347-1355
38. Ming Y.L., Song G., Chen L.H., Zheng Z.Z., Chen Z.Y., Ouyang G.L., et al. Anti-proliferation and apoptosis induced by a novel intestinal metabolite of ginseng saponin in human hepatocellular carcinoma cells. Cell Biol Int 31 (2007) 1265-1273
39. Yang Z.G., Sun H.X., and Ye Y.P. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem Biodivers 3 (2006) 187-197
40. Willimott S., Barker J., Jones L.A., and Opara E.I. Apoptotic effect of Oldenlandia diffusa on the leukaemic cell line HL60 and human lymphocytes. J Ethnopharmacol 114 (2007) 290-299
41. Spelman K., Burns J., Nichols D., Winters N., Ottersberg S., and Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 11 (2006) 128-150